ESC 2024 - Pardeep Jhund discusses the findings of a meta-analysis of 4 RCTs with MRAs in HF patients across the LVEF spectrum. According to Pardeep Jhund, these findings suggest that steroidal MRAs could be used in HFrEF and the non-steroidal MRA finerenone in HFmrEF/HFpEF.
Beneficial effects of MRAs in HF across the LVEF spectrum

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of the meta-analysis
Release date: 18 September 2024
Overview
ESC 2024 - Pardeep Jhund discusses the findings of a meta-analysis of 4 RCTs with MRAs in HF patients across the LVEF spectrum. According to Pardeep Jhund, these findings suggest that steroidal MRAs could be used in HFrEF and the non-steroidal MRA finerenone in HFmrEF/HFpEF.
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of the meta-analysis
Release date: 18 September 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?